Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL · Real-Time Price · USD
0.980
-0.670 (-40.62%)
At close: Dec 24, 2024, 1:00 PM
0.850
-0.130 (-13.24%)
After-hours: Dec 24, 2024, 4:55 PM EST
Sol-Gel Technologies Employees
Sol-Gel Technologies had 36 employees as of December 31, 2023. The number of employees decreased by 19 or -34.55% compared to the previous year.
Employees
36
Change (1Y)
-19
Growth (1Y)
-34.55%
Revenue / Employee
$325,194
Profits / Employee
-$265,833
Market Cap
27.29M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Accelerate Diagnostics | 134 |
IGC Pharma | 67 |
NKGen Biotech | 63 |
DURECT | 58 |
KALA BIO | 43 |
Daré Bioscience | 26 |
Intensity Therapeutics | 7 |
SLGL News
- 5 weeks ago - Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 4 months ago - UPDATE: Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 4 months ago - Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 5 months ago - Sol-Gel Technologies Announces Management Realignment - GlobeNewsWire
- 7 months ago - Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 7 months ago - Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel - GlobeNewsWire
- 9 months ago - Sol-Gel's Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream - GlobeNewsWire
- 10 months ago - Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments - GlobeNewsWire